1 Min Read
Oct 2 (Reuters) - CERENO SCIENTIFIC AB
* CERENO SCIENTIFIC RECEIVES REGULATORY APPROVAL TO START CLINICAL STUDY WITH ITS DRUG CANDIDATE CS1 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.